Bio-Techne to Present at Investor Conferences
Get Alerts TECH Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: -0.4%
Join SI Premium – FREE
Jefferies Global Healthcare Conference
Goldman Sachs 46th Annual Global Healthcare Conference
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: David Clair, Vice President, Investor Relations & Corporate Development
[email protected]
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-conferences-302467190.html
SOURCE Bio-Techne Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Starts Bio-Techne Corp. (TECH) at Neutral
- Wilmington NC Decluttering Tips Explained In HelloNation Article Featuring Organizing Expert Kristin Roser
- 49NORTH RELEASES GLOBAL PROCEDURE DESIGNER, A PROVEN INSTRUMENT FLIGHT PROCEDURE DESIGN SOLUTION REFRESHED FOR COMPLIANCE WITH LATEST REGULATIONS
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
William Blair, Goldman Sachs, Jefferies & Co, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share